Sheng Yao

4PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 07, 2022
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01).

Zhijie Wang, Lin Wu, Baolan Li

|May 26, 2022
The CD8α-PILRα interaction maintains CD8+ T cell quiescence.

Linghua Zheng, Xue Han, Sheng Yao

|Feb 23, 2022
Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysis.

Siming Li, Xiaowen Wu, Xieqiao Yan

|Jul 29, 2021
Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy.

Yi Sun, Wei Chen, Robert J Torphy

Pageof 1